The Medicines Company

MDCO

US5846881051

Pharmaceuticals

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+0.14%	-0.05%

2020	The Medicines Company Announces Board Changes	CI
2020	The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care	CI

Robert Savage Notifies The Medicines Company to Resign from the Board of Directors

August 18, 2016 at 04:47 pm EDT

On August 14, 2016, Robert Savage notified The Medicines Company of his decision to resign from the Board of Directors of the company for personal reasons effective immediately.

Latest news about The Medicines Company

The Medicines Company Announces Board Changes	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P TMI Index	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P 1000	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P Global BMI Index	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P Composite 1500	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P Biotechnology Select Industry Index	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from NASDAQ Biotechnology Index	20-01-06	CI
The Medicines Company(NasdaqGS:MDCO) dropped from NASDAQ Composite Index	20-01-06	CI
Novartis AG completed the acquisition of The Medicines Company.	20-01-02	CI
World share markets rally on revived trade hopes; dollar gains	19-11-25	RE
World share markets rally on revived trade hopes; dollar gains	19-11-25	RE
Transatlantic dealmaking sends European shares back to four-year peak	19-11-25	RE
Black Friday frenzy: Tiffany buys LVMH, Charles Schwab buys TD Ameritrade, Novartis buys Medicines Company…	19-11-25
Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker	19-11-25	RE
Transcript : Novartis AG, The Medicines Company - M&A Call	19-11-25
Novartis AG entered into definitive agreement to acquire The Medicines Company for $6.8 billion.	19-11-23	CI
Ionis Pharmaceuticals : Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion - WSJ	19-11-23	RE
Novartis Reportedly Holds Talks to Acquire Medicines Co	19-11-19	CI
Medicines : Novartis eyes Medicines Co to boost cardio franchise - report	19-11-19	RE
Transcript : The Medicines Company - Special Call	19-11-18
The Medicines Company Announces ORION-10 Study of Inclisiran in ASCVD Patients Showed Durable and Potent Lowering of LDL-C with Twice-Yearly Dosing	19-11-16	CI
The Medicines Company Announces Detailed Results from the ORION-9 and ORION-10 Pivotal Phase 3 Clinical Studies of Inclisiran	19-11-06	CI
Transcript : The Medicines Company, Q3 2019 Earnings Call, Oct 30, 2019	19-10-30

The Medicines Company is a global biopharmaceutical company. The Company is focused on the development of inclisiran, a twice-yearly therapy that allows administration during patients routine visits to their healthcare professionals and potentially contributes to improved patient adherence and sustained lower LDL-C levels. The Company is a subsidiary of Novartis AG.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
THE MEDICINES COMPANY	-0.05%	6.79B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.28%	44.4B
OTSUKA HOLDINGS CO., LTD.	+24.60%	23.03B
SANDOZ GROUP AG	+18.29%	15.14B
CIPLA LIMITED	+12.87%	13.12B
ZYDUS LIFESCIENCES LIMITED	+44.67%	11.85B
ONO PHARMACEUTICAL CO., LTD.	-8.33%	6.99B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.22%	5.52B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-6.31%	4.62B

Generic Pharmaceuticals

The Medicines Company

Equities

MDCO

US5846881051

Pharmaceuticals

Robert Savage Notifies The Medicines Company to Resign from the Board of Directors

Latest news about The Medicines Company

Chart The Medicines Company

Company Profile

Sector Generic Pharmaceuticals